Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors

Indoleamine 2,3-dioxygenase (IDO) plays a significant role in several disorders such as Alzheimer’s disease, age-related cataracts and tumors. A series of novel tryptoline derivatives were synthesized and evaluated for their inhibitory activity against IDO. Substituted tryptoline derivatives (11a, 1...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 21; no. 5; pp. 1159 - 1165
Main Authors Tanaka, Minoru, Li, Xin, Hikawa, Hidemasa, Suzuki, Takafumi, Tsutsumi, Katsuhiko, Sato, Masashi, Takikawa, Osamu, Suzuki, Hideharu, Yokoyama, Yuusaku
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 01.03.2013
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Indoleamine 2,3-dioxygenase (IDO) plays a significant role in several disorders such as Alzheimer’s disease, age-related cataracts and tumors. A series of novel tryptoline derivatives were synthesized and evaluated for their inhibitory activity against IDO. Substituted tryptoline derivatives (11a, 11c, 11e, 12b and 12c) were demonstrated to be more potent than known inhibitor MTH-Trp. Suzuki–Miyaura cross-coupling reaction of 11a–d with phenylboronic acid proceeded in high yields. In most cases, C5 and C6 substitutions on the corresponding indole ring were well tolerated. The tryptoline derivative 11c is a promising chemical lead for the discovery of novel IDO inhibitors.
Bibliography:http://dx.doi.org/10.1016/j.bmc.2012.12.028
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2012.12.028